NasdaqGS - Nasdaq Real Time Price USD

Healthcare Services Group, Inc. (HCSG)

11.19 -0.03 (-0.27%)
As of 11:15 AM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 5555
Avg. Estimate 0.20.20.820.87
Low Estimate 0.190.190.750.81
High Estimate 0.210.210.860.95
Year Ago EPS 0.12-0.070.520.82

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 5555
Avg. Estimate 426.87M432.26M1.72B1.78B
Low Estimate 424.8M429M1.71B1.76B
High Estimate 429.98M435.19M1.73B1.8B
Year Ago Sales 418.93M411.39M1.67B1.72B
Sales Growth (year/est) 1.90%5.10%3.00%3.30%

Earnings History

CURRENCY IN USD 6/30/2023 9/30/2023 12/31/2023 3/31/2024
EPS Est. 0.170.180.160.19
EPS Actual 0.12-0.070.310.21
Difference -0.05-0.250.150.02
Surprise % -29.40%-138.90%93.80%10.50%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.20.20.820.87
7 Days Ago 0.190.20.780.85
30 Days Ago 0.190.20.780.85
60 Days Ago 0.20.20.80.86
90 Days Ago 0.170.180.720.71

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 2132
Up Last 30 Days 2132
Down Last 7 Days --------
Down Last 30 Days ------1

Growth Estimates

CURRENCY IN USD HCSGIndustrySectorS&P 500
Current Qtr. 66.70%----1.50%
Next Qtr. 385.70%----11.40%
Current Year 57.70%----5.20%
Next Year 6.10%----13.40%
Next 5 Years (per annum) 9.00%----11.09%
Past 5 Years (per annum) -21.12%------

Research Analysis

Analyst Price Targets

13.00
14.50 Average
11.19 Current
17.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Benchmark: Buy to Buy 2/15/2024
Maintains UBS: Neutral to Neutral 2/15/2024
Maintains Baird: Neutral to Neutral 2/15/2024
Maintains RBC Capital: Outperform to Outperform 2/15/2024
Reiterates Benchmark: Buy to Buy 12/22/2023
Initiated UBS: Neutral 11/30/2023

Related Tickers